Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Anik R. Patel"'
Autor:
Olalekan O. Oluwole, Markqayne D. Ray, Richard M. Zur, Cheryl P. Ferrufino, Brett Doble, Anik R. Patel, S. Pinar Bilir
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionNovel therapies for 3L+ relapsed/refractory (r/r) follicular lymphoma (FL) have been approved recently by the US Food and Drug Administration including anti-CD19 CAR-T therapies such as axicabtagene ciloleucel (axi-cel) and CD20 × CD3 T-
Externí odkaz:
https://doaj.org/article/0bf9658a2eb640f7b7c7528ac49a045b
Autor:
Steve Kanters, Graeme Ball, Brad Kahl, Adriana Wiesinger, Eve H. Limbrick-Oldfield, Akshay Sudhindra, Julia Thornton Snider, Anik R. Patel
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Patients with follicular lymphoma (FL) can have high response rates to early lines of treatment. However, among FL patients relapsed/refractory (r/r) after ≥2 prior lines of therapy (LOT), remission tends to be shorter and there
Externí odkaz:
https://doaj.org/article/923b9b42936e48caa74f6508905b31ed
Autor:
Anik R. Patel, Richard T. Lester, Carlo A. Marra, Mia L. van der Kop, Paul Ritvo, Lidia Engel, Sarah Karanja, Larry D. Lynd
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background Health-related quality of life (HRQoL) and health state utility value (HSUV) measurements are vital components of healthcare clinical and economic evaluations. Accurate measurement of HSUV and HRQoL require validated instruments.
Externí odkaz:
https://doaj.org/article/d2ec01a16d16451f91e7d57f3eabadc0
Autor:
Anik R. Patel, Kelly V. Ruggles, Kimberly Nucifora, Qinlian Zhou, Stephen Schensul, Jean Schensul, Kendall Bryant, R. Scott Braithwaite
Publikováno v:
MDM Policy & Practice, Vol 3 (2018)
Background. Multilevel interventions combine individual component interventions, and their design can be informed by decision analysis. Our objective was to identify the optimal combination of interventions for alcohol-using HIV+ individuals on antir
Externí odkaz:
https://doaj.org/article/8a8918286d1d4d11adabfef29232213e
Autor:
Frederick L. Locke, Zhen-Huan Hu, Tanya Siddiqi, Caron A. Jacobson, Sarah Nikiforow, Sairah Ahmed, David B. Miklos, Yi Lin, Matthew A. Lunning, Brian T. Hill, Armin Ghobadi, Harry Miao, Shilpa Shahani, Clare Spooner, Christine Fu, Anik R. Patel, Hairong Xu, Marcelo C Pasquini
Publikováno v:
Blood. 140:7512-7515
Autor:
Matthew A. Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson, Sairah Ahmed, David B. Miklos, Yi Lin, Brian T. Hill, Armin Ghobadi, Sattva S. Neelapu, Jason Westin, Harry Miao, Shilpa Shahani, Anik R. Patel, Clare Spooner, Christine Fu, Hairong Xu, Marcelo C Pasquini
Publikováno v:
Blood. 140:1852-1855
Autor:
Paola Ghione, M Lia Palomba, Hervé Ghesquieres, Sabela Bobillo, Anik R Patel, Myrna Nahas, Steve Kanters, Kevin Deighton, Anthony Hatswell, Long Ma, Eve H. Limbrick-Oldfield, Julia Thornton Snider, Sally W. Wade, Maria Teresa Riberio, John Radford, Sara Beygi, John Gribben
Publikováno v:
Ghione, P, Palomba, M L, Ghesquieres, H, Bobillo, S, Patel, A R, Nahas, M, Kanters, S, Deighton, K, Hatswell, A, Ma, L, Limbrick-Oldfield, E H, Snider, J T, Wade, S W, Riberio, M T, Radford, J, Beygi, S & Gribben, J 2022, ' Treatment patterns and outcomes in relapsed/refractory follicular lymphoma : results from the international SCHOLAR-5 study ', Haematologica . https://doi.org/10.3324/haematol.2022.281421
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are limited. SCHOLAR-5 is a retrospective cohort study using data from adult
Autor:
Frederick L. Locke, Sattva S. Neelapu, Markqayne D. Ray, Eve H Limbrick-Oldfield, Sally W Wade, Steve Kanters, Anik R. Patel, Olalekan O. Oluwole
Publikováno v:
Blood. 140:7516-7518
Autor:
Olalekan O. Oluwole, Markqayne D. Ray, Katherine L. Rosettie, Graeme Ball, Jorge Jacob, Pinar Bilir, Anik R. Patel, Caron A. Jacobson
Publikováno v:
Blood. 140:10822-10824
Publikováno v:
Blood Advances.